Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Macular telangiectasia type 2

MONDO:1010183

A macular telangiectasia that causes slow deterioration of central vision, typically appearing in people between the ages of 50 and 60. It is characterized by the dilation and leakage of blood vessels in the macula, the part of the retina responsible for sharp, detailed vision, and is also linked to neurodegeneration in retinal cells.

Also known as: MacTel type 2, MacTel2

2 clinical trials for this condition and its sub-types.

Follow this condition to get notified about new trials

Broader categories

Disease (717) Eye disorder (104) Human disease (15) Disorder of orbital region (3) Disorder of visual system (1) Macular telangiectasia (1) Disease by body system or component (0)
Trials to join now! 1 Not yet recruiting 1
Sort by
  • Eye implant for rare vision loss gets Long-Term safety review

    Disease control Recruiting now

    This study looks at the long-term safety of an eye implant (NT-501) for people with MacTel type 2, a rare disease that damages the center of the retina. About 285 adults who already received the implant in earlier studies will be followed, and some who had a sham procedure can no…

    Phase 4 • Sponsor: Neurotech Pharmaceuticals • Aim: Disease control

    Last updated Aug 15, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space